Results for tag: "Neonatal Sepsis"

Neonatal sepsis is a severe infection in newborns, characterized by the presence of bacteria in the blood, which can lead to systemic inflammation and possibly life-threatening conditions. Within the context of Women's Health, managing and preventing neon grand sepsis is crucial as it directly affects the well-being of both the mother and the newborn child. Efforts to prevent and treat neonatal sepsis start with maternal health, as complications during pregnancy, delivery, and postpartum care can contribute to the risk. Proper antenatal care, hygiene during childbirth, and early recognition of risk factors in mothers can help decrease the incidence of neonatal sepsis. The market for neonatal sepsis involves the development and delivery of diagnostic, therapeutic, and preventive solutions. These range from rapid diagnostic tests and antimicrobial therapy to training and protocol development for healthcare providers that ensure timely and effective treatment. Notable companies in the neonatal sepsis market include: - Pfizer Inc., known for producing antibiotics used in sepsis treatment. - Merck & Co., Inc., which is involved in the development of vaccines and antimicrobial agents. - Roche Diagnostics, a division of Roche that offers advanced diagnostic technologies for the detection of neonatal infections. - Biomerieux, which specializes in diagnostic solutions for infectious diseases. - Becton, Dickinson and Company (BD), providing medical devices that facilitate specimen collection and diagnosis. - Gilead Sciences, Inc., engaged in the Show Less Read more